Skip to main content
. 2007 Sep;26(6):1657–1669. doi: 10.1111/j.1460-9568.2007.05769.x

Fig. 3.

Fig. 3

Regional and cellular distribution of SRR immunoreactivity in the human brain. (A) DPFC, demonstrating an enhancement of staining in white matter (wm) over grey matter (gm). (B) SRR immunoreactivity with cresyl violet counterstaining in DPFC grey matter, demonstrating immunolabelling of putative glia (arrows) amongst immunonegative pyramidal neurons (purple). (C) SRR immunoreactivity in the DPFC white matter localized to putative glia and as punctate white matter labelling. Inset: high-power image of SRR immunoreactivity in the hippocampal white matter. (D) SRR immunoreactivity in the cerebellum in the white matter (wm), granule cell layer (gcl), Purkinje cell layer (pcl) and molecular layer (ml). (E) SRR immunoreactivity in the cerebellum localized to Bergmann glia of the Purkinje cell layer (arrows a) and their radial processes (rp) in the molecular layer, putative glia of the granule cell layer (arrows b) and putative glia of the molecular layer (arrows c). Purkinje cells were occasionally moderately immunolabelled (inset). (F) Control section after omission of primary antibody. Scale bars = 1 mm (A), 0.5 mm (B), 50 µm (C–F).